GLAZER CAPITAL, LLC
SEC CIK 1076809 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| REVB | REVELATION BIOSCIENCES, INC. | 10% | 381.1K | — | $6.60M | 1 | 2021-09-21 | 2021-09-21 |
Most active insiders at REVB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zygmont Chester Stanley III | CFO | — | — |
| 2 | Rolke James | CEO, Dir | — | — |
| 3 | CARVER JENNIFER | Dir | — | — |
| 4 | Chawla Lakhmir S | Dir | — | — |
| 5 | ROPER JESS | Dir | — | — |
GLAZER CAPITAL, LLC made no open-market trades at REVB in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2021-09-23 | 2021-09-21+ | REVB | REVELATION BIOSCIENCES, INC. | GLAZER CAPITAL, LLC | 10% | S - Sale | $10.08 | -654.5K | 381.1K | -63% | -$6.60M |
Purchase Sale Sale after option exercise All abbreviations